Home > Press > 'Nanoglassblowing' Seen as Boon to Study of Individual Molecules
Left: Schematic of a T-junction nanofluidic device with a "nanoglassblown" funnel-shaped entrance to a nanochannel. The funnel tapers down to 150 micrometers (about the diameter of a human hair) at the nanochannel entrance.
Right: Photomicrograph of the T-junction with the first section of the nanochannel visible at the bottom. The colors are a white light interference pattern caused by the changing depth of the curved glass funnel.
Credit: Elizabeth Strychalski, Cornell University |
Abstract:
While the results may not rival the artistry of glassblowers in Europe and Latin America, researchers at the National Institute of Standards and Technology (NIST) and Cornell University have found beauty in a new fabrication technique called "nanoglassblowing" that creates nanoscale (billionth of a meter) fluidic devices used to isolate and study single molecules in solution—including individual DNA strands. The novel method is described in a paper posted online this week in the journal Nanotechnology.*
Traditionally, glass micro- and nanofluidic devices are fabricated by etching tiny channels into a glass wafer with the same lithographic procedures used to manufacture circuit patterns on semiconductor computer chips. The planar (flat-edged) rectangular canals are topped with a glass cover that is annealed (heated until it bonds permanently) into place. About a year ago, the authors of the Nanotechnology paper observed that in some cases, the heat of the annealing furnace caused air trapped in the channel to expand the glass cover into a curved shape, much like glassblowers use heated air to add roundness to their work. The researchers looked for ways to exploit this phenomenon and learned that they could easily control the amount of "blowing out" that occurred over several orders of magnitude.
As a result, the researchers were able to create devices with "funnels" many micrometers wide and about a micrometer deep that tapered down to nanochannels with depths as shallow as 7 nanometers—approximately 1,000 times smaller in diameter than a red blood cell. The nanoglassblown chambers soon showed distinct advantages over their planar predecessors.
"In the past, for example, it was difficult to get single strands of DNA into a nanofluidic device for study because DNA in solution balls up and tends to bounce off the sharp edges of planar channels with depths smaller than the ball," says Cornell's Elizabeth Strychalski. "The gradually dwindling size of the funnel-shaped entrance to our channel stretches the DNA out as it flows in with less resistance, making it easier to assess the properties of the DNA," adds NIST's Samuel Stavis.
Future nanoglassblown devices, the researchers say, could be fabricated to help sort DNA strands of different sizes or as part of a device to identify the base-pair components of single strands. Other potential applications of the technique include the manufacture of optofluidic elements—lenses or waveguides that could change how light is moved around a microchip—and rounded chambers in which single cells could be confined and held for culturing.
This work was supported in part by Cornell's Nanobiotechnology Center, part of the National Science Foundation's Science and Technology Center Program. It was performed while Samuel Stavis held a National Research Council Research Associateship Award at NIST.
* E.A. Strychalski, S.M. Stavis and H.G. Craighead. Non-planar nanofluidic devices for single molecule analysis fabricated using nanoglassblowing. Nanotechnology, Posted online the week of June 8, 2008.
####
About NIST
From automated teller machines and atomic clocks to mammograms and semiconductors, innumerable products and services rely in some way on technology, measurement, and standards provided by the National Institute of Standards and Technology.
Founded in 1901, NIST is a non-regulatory federal agency within the U.S. Department of Commerce. NIST's mission is to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve our quality of life.
For more information, please click here
Contacts:
Michael E. Newman
(301) 975-3025
Copyright © NIST
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||